Literature DB >> 18228247

TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation.

Tony J Vanden Bush1, Gail A Bishop.   

Abstract

During vaccination or infection, adaptive and innate immune receptors of B cells are engaged by microbial antigens/ligands. A better understanding of how innate and adaptive signaling pathways interact could enlighten B lymphocyte biology as well as aid immunotherapy strategies and vaccine design. To address this goal, we examined the effects of TLR stimulation on BCR and CD40-induced B cell activation. Synergistic production of IL-6 was observed in both human and mouse primary B cells stimulated through B cell antigen receptors, CD40 and TLR7, and these two receptors also cooperated independently of BCR signals. The enhanced IL-6 production was dependent upon the activity of c-Jun kinase (JNK) and cFos. Dual stimulation through CD40 and TLR7 markedly enhanced JNK activity. The increased level of active JNK in dual-stimulated cells was accompanied by an increase in the level of active AP-1 monomers cJun and cFos. The stimulation of B cells through both CD40 and TLR7 therefore enhanced the production of cytokines through increased JNK signaling and AP-1 activity. In addition, the dual stimulation increased cFos/AP-1 species in stimulated cells, effectively expanding the repertoire of AP-1 dimers as compared to singly stimulated B cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18228247      PMCID: PMC2951126          DOI: 10.1002/eji.200737602

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  51 in total

1.  The immune response modifier resiquimod mimics CD40-induced B cell activation.

Authors:  G A Bishop; L M Ramirez; M Baccam; L K Busch; L K Pederson; M A Tomai
Journal:  Cell Immunol       Date:  2001-02-25       Impact factor: 4.868

2.  Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848.

Authors:  G A Bishop; Y Hsing; B S Hostager; S V Jalukar; L M Ramirez; M A Tomai
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

Review 3.  A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

4.  Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment.

Authors:  D I Bernstein; C J Harrison; M A Tomai; R L Miller
Journal:  J Infect Dis       Date:  2001-02-13       Impact factor: 5.226

Review 5.  Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders.

Authors:  Kalanethee Paul-Pletzer
Journal:  Drugs Today (Barc)       Date:  2006-09       Impact factor: 2.245

Review 6.  B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms.

Authors:  Q Vos; A Lees; Z Q Wu; C M Snapper; J J Mond
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

Review 7.  Topical immunomodulators--progress towards treating inflammation, infection, and cancer.

Authors:  U R Hengge; B Benninghoff; T Ruzicka; M Goos
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

8.  Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells.

Authors:  M Baccam; G A Bishop
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

Review 9.  Interleukin-6: a new therapeutic target.

Authors:  Josef S Smolen; Ravinder N Maini
Journal:  Arthritis Res Ther       Date:  2006-07-28       Impact factor: 5.156

10.  Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells.

Authors:  Venky Ramakrishna; John P Vasilakos; Joseph D Tario; Marc A Berger; Paul K Wallace; Tibor Keler
Journal:  J Transl Med       Date:  2007-01-25       Impact factor: 5.531

View more
  34 in total

Review 1.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 2.  Roles of TRAF molecules in B lymphocyte function.

Authors:  Ping Xie; Zachary J Kraus; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2008-05-21       Impact factor: 7.638

Review 3.  Toll-like receptors: lessons to learn from normal and malignant human B cells.

Authors:  David Chiron; Isabelle Bekeredjian-Ding; Catherine Pellat-Deceunynck; Régis Bataille; Gaëtan Jego
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

4.  Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.

Authors:  John P Graham; Carissa R Moore; Gail A Bishop
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

Review 5.  Toll-like receptors and B cells: functions and mechanisms.

Authors:  Claire M Buchta; Gail A Bishop
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

6.  Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.

Authors:  T Layer; A Steele; J A Goeken; S Fleenor; P Lenert
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

7.  Human gestation-associated tissues express functional cytosolic nucleic acid sensing pattern recognition receptors.

Authors:  A H Bryant; G E Menzies; L M Scott; S Spencer-Harty; L B Davies; R A Smith; R H Jones; C A Thornton
Journal:  Clin Exp Immunol       Date:  2017-03-31       Impact factor: 4.330

8.  A novel polymorphism of the human CD40 receptor with enhanced function.

Authors:  Anna L Peters; Robert M Plenge; Robert R Graham; David M Altshuler; Kathy L Moser; Patrick M Gaffney; Gail A Bishop
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

9.  Phospholipase Cgamma2 is critical for Dectin-1-mediated Ca2+ flux and cytokine production in dendritic cells.

Authors:  Shengli Xu; Jianxin Huo; Koon-Guan Lee; Tomohiro Kurosaki; Kong-Peng Lam
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

10.  Antigen receptor signals rescue B cells from TLR tolerance.

Authors:  Jayakumar S Poovassery; Tony J Vanden Bush; Gail A Bishop
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.